NewsRx

Search our medical news database

Biolase Technology, Inc.

Medical laser maker receives notice of compliance from Nasdaq

Published in Pharma Investments, Ventures and Law Weekly, November 6th, 2005

Biolase Technology, Inc., (BLTI) received notice from The Nasdaq Stock Market that the company has evidenced compliance with all requirements for continued listing on the Nasdaq National Market and that effective at the market open on October 6, 2005, the company's trading symbol has been restored to "BLTI."

The company previously announced that it received notices of potential delisting due to the failure to timely file its fiscal 2004 Annual Report on Form 10-K (the 2004 Form 10-K) and its Quarterly Reports on Form 10-Q for the first and second fiscal quarters of 2005 (collectively, the "First and Second Quarter 10-Qs").

The company filed the 2004...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook